Table 1. Detailed summary of the patients undergoing prostatectomy.

Patient ID	GleasonScore	T stage	N stage	Marginstatus	Stephensonprediction	Pre-operation PSA(ng/ml)	Post-operation PSA(ng/ml)	Total CTC(counts/ml)	NIR+ CTC(counts/ml)	Live CTC(%)
1	3+3	pT2a	pN0	–	98%	4.76	<0.1	8	4	50%
2	3+4	pT2c	pN0	+	95%	2.7	<0.1	4	2	50%
3	3+4	pT2c	pN0	–	98%	1.9	<0.1	15	10	67%
4	3+4	pT2c	pN0	–	96%	4.6	<0.1	26	19	73%
5	3+4	pT2c	pNx	+	92%	8.34	<0.1	65	7	11%
6	3+3	pT2c	pN0	–	98%	4.5	<0.1	10	10	100%
7	3+3	pT2c	pN0	+	97%	4.33	<0.1	12	10	83%
8	3+4	pT2c	pN0	–	96%	4.54	<0.1	34	8	24%
9	3+4	pT2c	pNx	–	96%	5.2	<0.1	10	10	100%
10	4+3	pT2c	pN0	–	89%	6.96	<0.1	4	4	100%
11	3+3	pT2c	pNx	–	97%	9.16	<0.1	1	1	100%
12	3+4	pT2c	pN0	–	96%	4.9	<0.1	2	2	100%
13	3+4	pT2c	pN0	+	93%	5.9	<0.1	8	5	63%
14	3+4	pT2c	pN0	–	96%	5	<0.1	151	148	98%
15	3+3	pT2c	pN0	–	98%	1.53	<0.1	12	11	92%
16	3+4	pT2c	pN0	–	95%	7.69	<0.1	5	5	100%
17	3+3	pT2c	pNx	+	97%	4.35	<0.1	8	8	100%
18	3+3	pT2c	pN0	+	96%	5	<0.1	10	10	100%
19	3+4	pT2c	pN0	–	94%	14.02	<0.1	21	20	95%
20	3+4	pT2c	pN0	–	95%	7	<0.1	23	13	57%
21	3+3	pT2c	pN0	–	97%	7.3	<0.1	54	53	98%
22	3+4	pT2c	pN0	+	95%	2.79	<0.1	117	116	99%
23	3+4	pT2c	pN0	–	95%	5.7	<0.1	0	0
24	3+3	pT2c	pN0	–	96%	16.44	<0.1	26	26	100%
25	3+4	pT2c	pNx	+	96%	4.26	<0.1	6	5	83%
26	3+3	pT2c	pN0	–	98%	4.02	0.14	3	3	100%
27	3+4	pT3a	pN0	+	85%	5	<0.1	119	87	73%
28	3+4	pT3a	pN0	–	89%	6.1	<0.1	16	11	69%
29	4+5	pT3a	pN0	+	34%	33	0.43	57	46	81%
30	4+3	pT3a	pN0	–	79%	4.85	<0.1	14	13	93%
31	3+4	pT3a	pN0	–	90%	4.2	<0.1	53	48	91%
32	3+4	pT3a	pNx	+	84%	6.09	<0.1	22	10	45%
33	4+3	pT3a	pNx	–	78%	5.5	<0.1	141	132	94%
34	3+4	pT3a	pN0	–	87%	9.95	<0.1	8	7	88%
35	3+4	pT3a	pN0	–	89%	5.6	<0.1	8	8	100%
36	4+3	pT3a	pN0	–	77%	6.05	<0.1	46	43	93%
37	3+4	pT3a	pN0	+	86%	4.3	<0.1	26	19	73%
38	4+3	pT3b	pN0	+	32%	10	<0.1	8	7	88%
39	4+3	pT3b	pN1	+	15%	12.6	0.2	440	439	100%
40	3+3	pTx	pN0	+	N/A	9.67	<0.1	54	48	89%